KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Treasury Shares: 2018-2024

  • Elanco Animal Health's Treasury Shares rose 12.82% to $4.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.4 million, marking a year-over-year increase of 12.82%. This contributed to the annual value of $4.4 million for FY2024, which is 12.82% up from last year.
  • Latest data reveals that Elanco Animal Health reported Treasury Shares of $4.4 million as of Q4 2024, which was up 12.82% from $3.9 million recorded in Q4 2023.
  • Over the past 5 years, Elanco Animal Health's Treasury Shares peaked at $4.4 million during Q4 2024, and registered a low of $2.0 million during Q4 2022.
  • For the 3-year period, Elanco Animal Health's Treasury Shares averaged around $3.4 million, with its median value being $3.9 million (2023).
  • In the last 5 years, Elanco Animal Health's Treasury Shares declined by 9.09% in 2022 and then soared by 95.00% in 2023.
  • Over the past 5 years, Elanco Animal Health's Treasury Shares (Quarterly) stood at $2.4 million in 2020, then dropped by 8.33% to $2.2 million in 2021, then fell by 9.09% to $2.0 million in 2022, then skyrocketed by 95.00% to $3.9 million in 2023, then grew by 12.82% to $4.4 million in 2024.
  • Its last three reported values are $4.4 million in Q4 2024, $3.9 million for Q4 2023, and $2.0 million during Q4 2022.